Cited by 278RNA Research and SplicingAmyotrophic Lateral Sclerosis ResearchRNA regulation and disease

Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain

Open access
Rogelj, Boris, Easton, Laura E., Bogu, Gireesh K., Stanton, Lawrence W., Rot, Gregor, Curk, Tomaž, Zupan, Blaž, Sugimoto, Yoichiro +7 more·2012·Scientific Reports

Abstract

Fused in sarcoma (FUS) and TAR DNA-binding protein 43 (TDP-43) are RNA-binding proteins pathogenetically linked to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), but it is not known if they regulate the same transcripts. We addressed this question using crosslinking and immunoprecipitation (iCLIP) in mouse brain, which showed that FUS binds along the whole length of the nascent RNA with limited sequence specificity to GGU and related motifs. A saw-tooth binding pattern in long genes demonstrated that FUS remains bound to pre-mRNAs until splicing is completed. Analysis of FUS(-/-) brain demonstrated a role for FUS in alternative splicing, with increased crosslinking of FUS in introns around the repressed exons. We did not observe a significant overlap in the RNA binding sites or the exons regulated by FUS and TDP-43. Nevertheless, we found that both proteins regulate genes that function in neuronal development.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep00603

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TDP43 and FUS regulate distinct groups of alternative exons and target different sets of mRNAs in the cytoplasm.

    “TDP43 and FUS regulate distinct groups of alternative exons and target different sets of mRNAs in the cytoplasm178,181”

    From The neurogenetics of alternative splicing (2016) · cites this paper as [178]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 52 · Cited by 278

Authors
Rogelj, B., Easton, L. E., Bogu, G. K., Stanton, L. W., Rot, G., Curk, T., Zupan, B., Sugimoto, Y., Modic, M., Haberman, N., Tollervey, J., Fujii, R., Takumi, T., Shaw, C. E., & Ule, J.
Affiliations
  • King's College London (GB)
  • MRC Laboratory of Molecular Biology (GB)
  • Genome Institute of Singapore (SG)
  • University of Ljubljana (SI)
  • Buck Institute for Research on Aging (US)
  • Hiroshima University (JP)
Corresponding author
  • Shaw, Christopher E.
  • Ule, Jernej
Venue
Scientific Reports
Published
2012-08-28
Volume
2
Issue
1
Pages
603-603
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2007239552
Cited by
278
References
52
Citations by year
2026: 8 · 2025: 7 · 2024: 14 · 2023: 12 · 2022: 15 · 2021: 22 · 2020: 22 · 2019: 24 · 2018: 26 · 2017: 25 · 2016: 32 · 2015: 25 · 2014: 22 · 2013: 21 · 2012: 3
FWCI
9.07
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
  • Wellcome Trust (089701, 089701/Z/09/Z)
  • Ministry of Education, Culture, Sports, Science and Technology (CREST)
  • Javna Agencija za Raziskovalno Dejavnost RS (J3-4026, J2-2197, L2-1112, P2-0209, Z7-3665)
  • Medical Research Council (MC_G1000733)
  • Japan Society for the Promotion of Science (22500335)
  • Core Research for Evolutional Science and Technology
  • FP7 Ideas: European Research Council (206726)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Keywords
FUS, TDP-43, alternative splicing, nascent RNA, RNA-binding proteins, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, pre-mRNA splicing, neuronal development, iCLIP
MeSH terms
Animals, Base Sequence, Brain, DNA-Binding Proteins, Exons, Gene Expression Regulation, Humans, Male, Neurons, Protein Binding, RNA Precursors, Alternative Splicing, Mice, Knockout, Gene Order, RNA-Binding Protein FUS, Mice, RNA Isoforms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review